SUMMARY The treatment of pain in acute myocardial infarction varies with local practice. Narcotic analgesics are still the usual treatment in many hospitals. Knowledge of optimal doses, duration of pain relief, and time between drug administration and pain relief is inadequate. Many studies indicate that the relief of pain is often incomplete after' treatment with narcotic analgesics. There is often a need for altemative treatments. Large randomised studies consistently show that fi blockade, initially given intravenously and then orally, relieves pain and reduces the need for analgesics. Studies also indicate that early administration of streptokinase and glyceryl trinitrate relieves pain. There is evidence that drugs that limit ischaemic damage also relieve pain.
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Chest pain is the most obvious clinical marker of myocardial ischaemia in the acute phase of a suspected acute myocardial infarction. Pain relief is important, not only for patient well being, but also because pain can induce systemic circulatory effects such as an increase in blood pressure, heart rate, and stroke volume. These changes may adversely influence the balance between myocardial metabolic requirement and supply and result in infarct extension. Various treatments have been suggested ranging from pure analgesics, particularly narcotics or tranquillisers, to drugs that have a direct or indirect effect on the ischaemic myocardium.'' Narcotic analgesics DRUGS The most commonly used agents are morphine, pethidine, pentazocine, methadone, and diamorphine (heroin). Morphine and diamorphine are the most popular because they have been more extensively studied and have better haemodynamic effects than, for example, pentazocine.
RELIEF OF PAIN
The analgesic effect is said to be the result of an increased pain threshold and a reduced sympathetico-adrenal response. Relief suggested that diamorphine induces a more rapid but not more pronounced increase in pCO2 and a more pronounced decrease in P02 than morphine. Respiratory insufficiency seems to be rare after treatment with narcotic analgesics in acute myocardial infarction. There was respiratory failure in 1 % of patients given morphine and 3% of patients given pethidine in acute myocardial infarction." Cenitral nervous system Nausea was reported in 20-30% of patients given morphine or pethidine"1 and 5-15% of patients treated with narcotic analgesics vomited.'5 Vertigo occurred in 10-30% of patients.'5 All these symptoms are common in acute myocardial infarction and it is difficult to assess their association with drug treatment. f Blockers
It is more than 10 years since the first report that intravenous administration of f blockers to selected patients in the early phase of acute myocardial infarction relieved pain within a few minutes, an In the Metoprolol in Acute Myocardial Infarction on (MIAMI) Trial which included 5778 patients randomised to either metoprolol or placebo treatment,24 the estimated number of hours of pain was reduced by 17%. The number ofpatients with severe chest pain (defined as pain requiring at least four injections of narcotic analgesics in combination with glyceryl trinitrate and calcium antagonist) was reduced by 42% in the metoprolol group.
SUBGROUP ANALYSIS
In two metoprolol studies the authors assessed the distribution of pain relief in different subgroups.2324 In both the effect was most pronounced in patients with a high initial rate-pressure product. In patients with either a low initial systolic blood pressure (< 120 mm Hg) or a low initial heart rate (< 60 beats/ min) the pain course was similar in patients given metoprolol and placebo, as judged by their requirement for analgesics. To some extent this explains why reliefofchest pain was better in patients with anterior infarction than in those with inferior infarction. 2324 The patients' requirement for analgesics was reduced to a similar extent both in the study in which metoprolol was started very early and in the study in which it was started later.
MECHANISMS OF THE PAIN RELIEVING EFFECT OF 0 BLOCKADE
There are several possible explanations for the pain relief produced by 0 blockade in suspected acute myocardial infarction. A reduction in heart work (reduced heart rate, systolic blood pressure, and contractility) improves the relation between coronary perfusion (access of oxygen and nutrients and washout of metabolites) and the myocardial metabolic demand.
A reduction in myocardial metabolic demand reduces the requirement for coronary flow in normal areas, which may cause redistribution of flow to ischaemic areas. In addition, a reduced heart rate prolongs the diastolic perfusion period. In experimental studies in animals, propranolol and metoprolol increased collateral circulation to the ischaemic myocardium.2 '27 Since it is thought that pain comes only from an ischaemic myocardium, one hypothesis is that pain relief is promoted by reduced ischaemia. The reduction in ST elevation and the rate-pressure product, which were seen in association with pain relief, supports this hypothesis. However, the relation between the decrease in rate-pressure product and the relief ofpain after administration of f blockade is not always close. 47 patients with acute myocardial infarction.7 There was a positive correlation between the nurses' and the patients' estimations (f = 0-76; p < 0-001). The nurses underestimated the patient's pain on 23% of occasions and overestimated it in 20%. Overestimation was more common at higher heart rates and blood pressures. This study also found that patients who said that they had severe pain were not always given pain relief.
Clinical implications
We believe that the initial treatment of pain in acute myocardial infarction should be based on antiischaemic drugs.
Patients who present soon after the onset of pain with the electrocardiographic changes of acute infarction, should be given immediate thrombolytic treatment if there are no contraindications. We think that f blockers should also be given promptly to suitable patients in whom the heart rate is > 50-60 beats/min. Although such treatment will reduce pain in many patients, the effect is unpredictable and narcotic analgesics should be given quickly if necessary. We cannot be certain how well patients will tolerate such a combination of treatment but we can recommend it provided there is careful monitoring of the heart rate and systolic blood pressure. If pain continues, a glyceryl trinitrate infusion should probably be started. Subsequent treatment depends on local experience. More experience of the effect of anti-inflammatory drugs, sedatives, and epidural anaesthesics is needed before these alternatives can be widely recommended.
Future aspects Narcotic analgesics such as morphine will remain the first line treatment of severe pain in acute myocardial infarction, but drugs with a more rapid effect that give better pain relief need to be developed. This in combination with the development of anti-ischaemic drugs should improve the treatment of pain in suspected acute myocardial infarction. Because pain is most intense in the early phase45 treatment should be started before the patient is admitted to hospital.
